- Home
- BAM vs CAH Comparison
BAM vs CAH Comparison
Compare BAM & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BAM | CAH |
|---|---|---|
| Founded | 2022 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.4B | 55.6B |
| IPO Year | 2022 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BAM | CAH |
|---|---|---|
| Price | $52.38 | $231.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 12 |
| Target Price | $60.83 | ★ $232.27 |
| AVG Volume (30 Days) | ★ 2.5M | 1.9M |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.94% | 1.01% |
| EPS Growth | N/A | ★ 12.09 |
| EPS | N/A | ★ 7.23 |
| Revenue | $4,817,000,000.00 | ★ $254,248,000,000.00 |
| Revenue This Year | $29.89 | $17.36 |
| Revenue Next Year | $14.70 | $9.06 |
| P/E Ratio | $34.43 | ★ $32.14 |
| Revenue Growth | ★ 21.03 | 14.23 |
| 52 Week Low | $42.20 | $145.87 |
| 52 Week High | $62.57 | $258.30 |
Technical Indicators
Market Signals| Indicator | BAM | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 55.35 | 47.80 |
| Support Level | $51.34 | $216.98 |
| Resistance Level | $53.61 | $231.90 |
| Average True Range (ATR) | 1.47 | 6.69 |
| MACD | -0.27 | -1.00 |
| Stochastic Oscillator | 23.83 | 9.52 |
Price Performance
Historical ComparisonAbout BAM Brookfield Asset Management Inc Limited Voting Shares
Brookfield Asset Management is one of the world's largest alternative-asset managers, with USD 1.181 trillion in total managed assets, including USD 602.7 billion in fee-earning AUM, at the end of 2025. The company has three main business segments: credit strategies (USD 363.0 billion in total AUM and USD 279.4 billion in fee-earning AUM), private equity (USD 155.0 billion/USD 48.0 billion), and real estate/real assets (USD 663.0 billion/USD 275.3 billion). The firm primarily serves institutional investors (90% of AUM) and high-net-worth individuals (10%), and is diversified globally, with 67% of revenue from the Americas, 20% from EMEA, and 13% from Asia-Pacific. Canada-based Brookfield Corp. owns 73% of Brookfield's outstanding Class A shares.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.